• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR TREK RX CORONARY DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR TREK RX CORONARY DILATATION CATHETER Back to Search Results
Catalog Number 1012271-12
Device Problems Inflation Problem (1310); Difficult to Remove (1528); Material Rupture (1546); Material Separation (1562); Improper or Incorrect Procedure or Method (2017)
Patient Problems Embolism (1829); Low Blood Pressure/ Hypotension (1914)
Event Date 08/20/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device was received.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a heavily calcified, re-stenosed stent lesion at a bifurcation in the posterior descending artery (pda) and posterior left ventricular artery (plva).This lesion was previously stented.The vessels were wired and pre-dilated with smaller balloons.Then, a 2.25 x 12 mm trek rx was advanced to the lesion, and inflated but didn't dilate enough, as a waist was noted in the balloon, so they over-inflated the balloon to dilate the calcified lesion.The balloon ruptured during the second inflation at 28 atmospheres.Resistance was met during removal and it was noted that the distal tip of the balloon separated and remained in the vessel.No flow was observed into the pda.The patient became unstable but was stabilized and taken urgently to surgery to remove the separated balloon segment.Patient was stable post-surgery.No additional information was provided.
 
Manufacturer Narrative
Exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.Visual inspection was performed on the returned portion of the device.The separated distal balloon and the inner member were not returned.The reported balloon rupture and separation were confirmed.The reported inflation issue could not be replicated in a testing environment due to the condition of the returned device.The reported difficulty to remove could not be replicated in a testing environment as it was based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.The reported patient effects of embolism and hypotension are listed in the coronary dilatation catheters (cdc), trek rx global instructions for use (ifu), as known patient effects.Additionally, the ifu states: balloon pressure should not exceed the rated burst pressure (rbp).The rbp for the trek rx device is 14 atm; therefore, rbp was exceeded.The investigation determined the reported balloon rupture appears to be related to user error.The reported inflation issue, difficulty removing the device, separation, surgical procedure, foreign body removal, treatment with medication and hospitalization appear to be related to operational context.A conclusive cause for the reported patient effects of embolism and hypotension and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respects to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TREK RX CORONARY DILATATION CATHETER
Type of Device
CORONARY DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key8994831
MDR Text Key159140392
Report Number2024168-2019-11694
Device Sequence Number1
Product Code LOX
UDI-Device Identifier08717648138218
UDI-Public08717648138218
Combination Product (y/n)N
PMA/PMN Number
K103110
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 11/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/11/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2022
Device Catalogue Number1012271-12
Device Lot Number90603G1
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/26/2019
Date Manufacturer Received10/29/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age78 YR
-
-